Differential Manifestations of Inflammatory Bowel Disease Based on Race and Immigration Status

• Published in: Gastro hep advances Vol. 3; no. 3; pp. 326 - 332
• Main Authors: Khalessi, Ali, Crowe, Brooks R., Xia, Yuhe, Rubinfeld, Gregory, Baylor, Jessica, Radin, Arielle, Liang, Peter S., Chen, Lea Ann
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.01.2024; Elsevier
• Subjects: Crohn’s Disease; Ethnicity; Health Status Disparities; Prognosis; Ulcerative Colitis; Crohn’s Disease; CD; ICD-9 and ICD-10; Ethnicity; Prognosis; Health Status Disparities; Ulcerative Colitis; IBD; UC
• ISSN: 2772-5723; 2772-5723
• DOI: 10.1016/j.gastha.2023.11.021

The prevalence of inflammatory bowel disease (IBD) is increasing globally. In this context, identifying risk factors for severe disease is important. We examined how race/ethnicity and immigration status influence IBD manifestations, treatments, and outcomes in a diverse, tertiary-care safety-net hospital. We conducted a single-center retrospective review of all IBD inpatients and outpatients treated from 1997–2017. Using logistic regression modeling, we compared disease onset, treatment, and outcomes by race (White, Black, Hispanic, or Asian) and immigration status (US-born vs foreign-born). A total of 577 patients were identified, of which 29.8% were White, 27.4% were Hispanic, 21.7% were Black, and 13.0% were Asian. Compared to Whites, Asians were more likely to be male (odds ratio [OR] 2.63, 95% confidence interval [CI]: 1.45, 5.00), whereas Blacks were more likely to be diagnosed with Crohn’s disease (OR 1.75, 95% CI: 1.10, 2.77) and more likely to undergo IBD-related intestinal resection (OR 2.49, 95% CI: 1.40, 4.50). Compared to US-born patients, foreign-born patients were more likely to be diagnosed with ulcerative colitis (OR 1.77, 95% CI: 1.04, 3.02). They were also less likely to be diagnosed before 16 years of age (OR 0.19, 95% CI: 0.08, 0.41), to have undergone intestinal resections (OR 0.39, 95% CI: 0.19, 0.83), to have received biologics (OR 0.43, 95% CI: 0.25, 0.76), or to have had dermatologic manifestations (OR 0.12, 95% CI: 0.03, 0.41). IBD phenotype varies by race, although foreign-born patients of all races show evidence of later-onset and milder disease. These findings may aid in disease prognostication and clinical management and, furthermore, may provide insight into intrinsic and environmental influences on IBD pathogenesis.